$53M genetic testing fraud | Walgreens completes CareCentrix deal

Having trouble viewing this email? See the online version

Wednesday, August 31, 2022

DOJ accuses lab owner of $53M genetic testing fraud

The owner of labs in three states allegedly paid kickbacks and bribes from 2019 to 2021 for unnecessary genetic cancer screening referrals.

Walgreens acquires majority share of CareCentrix

Walgreens Boots Alliance completed a $330 million deal to purchase 55% of CareCentrix, a home health benefit management company.

CMS proposes big changes to Medicaid, CHIP enrollment

The proposed rule precedes the looming resumption of eligibility redeterminations, which are expected to cause 15 million people to lose benefits when the COVID-19 public health emergency lapses.

Oscar Health loses big customer

Oscar Health’s deal with Health First was expected to generate $60 million in revenue in 2022.

Behavioral health provider shortage strains systems, communities

Shortages have disproportionately impacted low-income Americans, as nearly 1 of 4 behavioral health prescribers did not see any Medicaid beneficiaries in 2020, new data shows.